İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2023 · article

Epidemiology of surgery associated acute kidney injury (EPIS-AKI): a prospective international observational multi-center clinical study

Dergi Springer Science and Business Media LLC ISSN kaydı başka bir dergiye işaret ediyor; ad YÖKSİS kaydından.
ISSN0342-4642
YÖKSİS OpenAlex Açık erişim · hybrid Üst %1
Yıl2023
Atıf165OpenAlex
Atıf154Semantic Scholar · 16 etkili
Yüzdelik%99,8
FWCI23,951,00 = dünya ortalaması
Scopus (SJR)Q1
WoS (JCR)Q1

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıSpringer Science and Business Media LLC
  • Katalog eşleşmesi (ISSN)Intensive Care Medicine
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

PURPOSE: The incidence, patient features, risk factors and outcomes of surgery-associated postoperative acute kidney injury (PO-AKI) across different countries and health care systems is unclear. METHODS: We conducted an international prospective, observational, multi-center study in 30 countries in patients undergoing major surgery (> 2-h duration and postoperative intensive care unit (ICU) or high dependency unit admission). The primary endpoint was the occurrence of PO-AKI within 72 h of surgery defined by the Kidney Disease: Improving Global Outcomes (KDIGO) criteria. Secondary endpoints included PO-AKI severity and duration, use of renal replacement therapy (RRT), mortality, and ICU and hospital length of stay. RESULTS: We studied 10,568 patients and 1945 (18.4%) developed PO-AKI (1236 (63.5%) KDIGO stage 1500 (25.7%) KDIGO stage 2209 (10.7%) KDIGO stage 3). In 33.8% PO-AKI was persistent, and 170/1945 (8.7%) of patients with PO-AKI received RRT in the ICU. Patients with PO-AKI had greater ICU (6.3% vs. 0.7%) and hospital (8.6% vs. 1.4%) mortality, and longer ICU (median 2 (Q1-Q3, 1-3) days vs. 3 (Q1-Q3, 1-6) days) and hospital length of stay (median 14 (Q1-Q3, 9-24) days vs. 10 (Q1-Q3, 7-17) days). Risk factors for PO-AKI included older age, comorbidities (hypertension, diabetes, chronic kidney disease), type, duration and urgency of surgery as well as intraoperative vasopressors, and aminoglycosides administration. CONCLUSION: In a comprehensive multinational study, approximately one in five patients develop PO-AKI after major surgery. Increasing severity of PO-AKI is associated with a progressive increase in adverse outcomes. Our findings indicate that PO-AKI represents a significant burden for health care worldwide.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

165atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 32 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
  2. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
  3. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trial.Atıf 29 · OpenAlex
  4. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
  5. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
  6. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
  7. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
  8. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex
  9. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS‑AKI trialAtıf 29 · OpenAlex
  10. 2024 Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trialAtıf 29 · OpenAlex

Yazarlar

5
  1. Alexander Zarbock 1
  2. RAPHAEL WEISS 2
  3. FELIX ALBERT 3
  4. YAVUZ ORAK KAHRAMANMARAŞ SÜTÇÜ İMAM ÜNİVERSİTESİ 4
  5. MUSTAFA SONER ÖZCAN SÜLEYMAN DEMİREL ÜNİVERSİTESİ 5